InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.70
(
-0.17%
)
US TECH 100
19,392.80
(
-0.40%
)
Dow Jones
42,146.82
(
-0.39%
)
Brent Oil
71.80
(
0.13%
)
Bitcoin
63,346.00
(
-3.48%
)
Post# of 253255
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120512
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: ghmm post# 68107

Sunday, 11/02/2008 12:35:06 PM

Sunday, November 02, 2008 12:35:06 PM

Post# of 253255
Re: AASLD (comments welcome)

>I thought we would be getting a lot more PR's and company calls. I only saw Pharmasset with a call today.<

Compared to 2007 and 2006, 2008 is a low-key AASLD; most of the sexy data have been previously released in sufficient detail to render the actual presentations anticlimactic.

The above is especially true for Telaprevir and Boceprevir—yesterday’s PR’s (in the links posted by ‘go seek’) contain few details not previously announced.

I’ll post the full Telaprevir and Boceprevir PR’s for archival purposes, and I invite comment form anyone who wishes to elaborate on how they expand on what we already knew.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up